CORONA, CA, Sep 05, 2008 (MARKET WIRE via COMTEX News Network) -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty
pharmaceutical company, today announced a change to its presentation
time at the Morgan Stanley Global Healthcare Unplugged Conference
that is being held on Tuesday, September 9, 2008. Paul Bisaro,
Watson's president and chief executive officer, will provide an
overview and update of the Company's business at 8:00 a.m. Eastern
This presentation will be webcast live and can be accessed on Watson
Pharmaceuticals' Investor Relations Web site at http://ir.watson.com.
The webcast can also be accessed at the following URL:
An archived version will be available for 60 days after the live
presentation and can be accessed at the same locations.
About Watson Pharmaceuticals, Inc.
Watson Pharmaceuticals, Inc., headquartered in Corona, California, is
a leading specialty pharmaceutical company that develops,
manufactures, markets, sells and distributes brand and generic
pharmaceutical products. Watson pursues a growth strategy combining
internal product development, strategic alliances and collaborations
and synergistic acquisitions of products and businesses. For press
releases and other company information, visit Watson Pharmaceuticals'
Web site at http://www.watson.com.
Watson Pharmaceuticals, Inc.
SOURCE: Watson Pharmaceuticals